COVID-19 vaccine makers Cyrus Poonawalla, Krishna Ella, Suchitra Ella to receive Padma Bhushan
2 years, 10 months ago

COVID-19 vaccine makers Cyrus Poonawalla, Krishna Ella, Suchitra Ella to receive Padma Bhushan

India TV News  

Highlights COVID-19 vaccine makers will receive the Padma Bhushan award. COVID-19 vaccine makers Cyrus Poonawalla, Krishna Ella and Suchitra Ella have been awarded Padma Bhushan, the country's third-highest civilian award, on Tuesday. Poonawalla's Serum Institute of India manufactures COVID-19 vaccine Covishield, while Bharat Biotech of Krishna Ella and Suchitra Ella produces India's indigenous coronavirus vaccine Covaxin. Subbanna Ayyappan, Ajai Kumar Sonkar, Sanjaya Rajaram, Sanghamitra Bandyopadhyay, Aditya Prasad Dash, Moti Lal Madan, Anil Kumar Rajvanshi, and Jyantkumar Maganlal Vyas have been awarded Padma Shri under the science and technology category. Under the medicine category, Dr. Himmatrao Bawaskar, Dr. Prokar Dasgupta, Dr. Lata Desai, Dr. Vijaykumar Vinayak Dongre, Dr. Narendra Prasad Misra, Dr. Sunkara Venkata Adinarayana Rao, Dr. Veeraswamy Seshiah, Dr. Bhimsen Singhal, Dr. Balaji Tambe, and Dr. Kamlakar Tripathi were awarded Padma Shri, the fourth-highest civilian award.

Ella Vaccine Bhushan Padma Padma Shri Padma Bhushan Cyrus Poonawalla Krishna Ella Suchitra Ella  padma  krishna  suchitra  cyrus  awarded  poonawalla  makers  dr  shri  receive  vaccine  covid19  ella  bhushan

History of this topic

Sharad Pawar proposes Bharat Ratna for Dr Ponawalla
10 months, 1 week ago

Sharad Pawar proposes Bharat Ratna for Dr Ponawalla

Hindustan Times  

Following the Serum Institute of India’s contribution to humanity and healthcare Nationalist Congress Party supremo, Sharad Pawar on Wednesday lauded Dr Cyrus Poonawalla’s contribution and suggested that the government award him the Bharat Ratna Award. The award is a recognition of Dr Poonawalla’s significant contributions to national development, particularly in the field of public health through vaccine manufacturing. Thanking the …

With State prod, India can be world leader in vaccines
10 months, 4 weeks ago

With State prod, India can be world leader in vaccines

Hindustan Times  

The World Health Organization activated its incident management support team as part of its emergency response framework on the emergence of a cluster of atypical pneumonia cases emerging from Wuhan, China, on January 1, 2020. India, the dark horse in the vaccine race, did the unexpected and against all odds, approving EUA to two vaccines — “made in India” Covishield …

Braving a Viral Storm tells the tale of India’s COVID vaccine journey
1 year, 11 months ago

Braving a Viral Storm tells the tale of India’s COVID vaccine journey

The Hindu  

India’s development and production of its own vaccines against COVID-19 was an important part of dealing with the pandemic, pushed by Prime Minister Narendra Modi’s view that the “entrepreneurial state” of government would bear the front-loaded risks of the effort, cushioning the private sector, according to a new book. The authors of Braving a Viral Storm: India’s Covid-19 Vaccine Story, …

Covovax vaccine will get approval in next 10-15 days, says SII CEO Poonawalla
1 year, 11 months ago

Covovax vaccine will get approval in next 10-15 days, says SII CEO Poonawalla

Hindustan Times  

Chief Executive Officer of Serum Institute of India, Adar Poonawalla, has said their Covovax vaccine will get approval as a booster dose against Covid-19 in the next 10 to 15 days. Adar Poonawalla, chief executive officer of Serum Institute of India Speaking to reporters on the sidelines of an event at the Bharati Vidyapeeth University here on Sunday, the SII …

Biological E, Bharat Biotech Together Sitting on Stockpile of 250 Million Covid Vaccine Doses
1 year, 11 months ago

Biological E, Bharat Biotech Together Sitting on Stockpile of 250 Million Covid Vaccine Doses

News 18  

Two major vaccine makers from Hyderabad, Biological E Ltd and Bharat Biotech, together are holding about 250 million doses of Covid-19 vaccines ready to dispatch as and when orders are received. According to respective company sources, Biological E is holding 200 million doses of its Covid-19 vaccine Corbevax while Bharat Biotech is sitting on a stockpile of 50 million doses …

Covid: Biological E, Bharat Biotech together holding 250 million vaccine doses
1 year, 11 months ago

Covid: Biological E, Bharat Biotech together holding 250 million vaccine doses

Live Mint  

The two major Hyderabad-based vaccine manufacturing units, Biological E and Bharat Biotech, together are holding about 250 million Covid vaccine doses ready to dispatch as and when orders are received, according to news agency PTI. Currently, Biological E is holding 200 million doses of its Covid-19 vaccine Corbevax while Bharat Biotech is sitting on a stockpile of 50 million doses …

Biological E, Bharat Biotech have stockpile of 250 million COVID vaccine doses
1 year, 11 months ago

Biological E, Bharat Biotech have stockpile of 250 million COVID vaccine doses

India TV News  

As Covid cases are increasing in the country, now focus is back on vaccination drive. According to sources- two major vaccine makers from Hyderabad, Biological E Ltd and Bharat Biotech, together have about 250 million doses of COVID-19 vaccines ready to dispatch as and when orders are received. Corbevax and Covaxin stocks Biological E held 200 million doses of its …

India need not panic given excellent COVID-19 vaccination coverage: Adar Poonawalla
2 years ago

India need not panic given excellent COVID-19 vaccination coverage: Adar Poonawalla

The Hindu  

Serum Institute of India CEO Adar Poonawalla on Tuesday expressed concern over reports of a rising COVID-19 graph in China but said there is no need to panic as the vaccination coverage in India is excellent. Mr. Poonawalla's tweet came a day after the Union Health Ministry urged all states and UTs to ramp up the whole genome sequencing of …

Corbevax Gets DCGI Approval As Covid-19 Vaccine Booster Dose For 18 Years And Above
2 years, 6 months ago

Corbevax Gets DCGI Approval As Covid-19 Vaccine Booster Dose For 18 Years And Above

ABP News  

New Delhi: The Drug Controller General of India approved the Corbevax Covid-19 booster as heterologous Covid-19 booster dose for adults above the age of 18 years who got their primary Covid-19 vaccination of Covishield or Covaxin administered six months before, reported news agency ANI. Recently, BE has furnished its clinical trials data to the DCGI who after a detailed evaluation …

Indian Covid vaccines better than Pfizer, Moderna, says Adar Poonawalla
2 years, 8 months ago

Indian Covid vaccines better than Pfizer, Moderna, says Adar Poonawalla

India Today  

Serum Institute of India CEO Adar Poonawalla on Wednesday claimed that Covid-19 vaccines that are made in India, have provided more protection against coronavirus infection than vaccines like Pfizer and Moderna. Speaking to news agency ANI, Poonawalla said, "The Covid-19 vaccines which have been made in India are providing more protection against the disease than mRNA vaccines like Pfizer and …

COVID-19: Indian vaccines better than Pfizer, Moderna, says Adar Poonawalla
2 years, 8 months ago

COVID-19: Indian vaccines better than Pfizer, Moderna, says Adar Poonawalla

Firstpost  

The COVID-19 vaccines which have been made in India are providing more protection against the disease than mRNA vaccines like Pfizer and Moderna, said Adar Poonawalla New Delhi: Serum Institute of India CEO Adar Poonawalla on Wednesday claimed that “Made in India” COVID-19 vaccines have provided more protection against the coronavirus infection than mRNA vaccines like Pfizer and Moderna. “The …

Covaxin to be evaluated as COVID-19 vaccine candidate in US, says Bharat Biotech
2 years, 10 months ago

Covaxin to be evaluated as COVID-19 vaccine candidate in US, says Bharat Biotech

India TV News  

Highlights Covaxin will be evaluated as a COVID-19 vaccine candidate in United States, Bharat Biotech said. COVAXIN will be evaluated as a COVID-19 vaccine candidate in the United States, said Bharat Biotech on Saturday. In a statement, Ocugen Inc, Bharat Biotech's partner in the US and Canada for Covaxin, noted that the American health regulator -- the US Food and …

Covid Vaccine Makers Cyrus Poonawalla, Krishna Ella & Suchitra Ella to Receive Padma Bhushan
2 years, 10 months ago

Covid Vaccine Makers Cyrus Poonawalla, Krishna Ella & Suchitra Ella to Receive Padma Bhushan

News 18  

Covid-19 vaccine makers named Cyrus Poonawalla, founder of Pune-based Serum Institute of India ; and Covaxin maker Bharat Biotech Chairman Krishna Ella and his co-founder wife Suchitra Ella will be awarded Padma Bhushan as announced by the Centre on Tuesday evening. Let’s have a peek at the outstanding life and career of these Padma Bhushan awardees: Cyrus Poonawalla Born in …

Padma Awards for this Year: N Chandrasekaran, Cyrus Poonawalla, Satya Nadella Among Awardees
2 years, 10 months ago

Padma Awards for this Year: N Chandrasekaran, Cyrus Poonawalla, Satya Nadella Among Awardees

News 18  

Tata Group’s N Chandrasekaran, Microsoft’s Satya Nadella, Alphabet’s Sundar Pichai are among the list of 17 awardees to receive the Padma Bhushan this year. The list comprises four Padma Vibhushan, 17 Padma Bhushan and 107 Padma Shri Awards. Serum Institute of India’s managing director Cyrus Poonawalla and Bharat Biotech’s Krishna Ella and Suchitra Ella will also be conferred with Padma …

Covaxin booster shot neutralises Omicron, says Bharat Biotech
2 years, 11 months ago

Covaxin booster shot neutralises Omicron, says Bharat Biotech

Hindustan Times  

India's vaccine-maker Bharat Biotech on Wednesday said that a booster dose of its Covid-19 vaccine ‘Covaxin’ neutralises both the Omicron and Delta variants of the coronavirus. The study, "The neutralisation activity of Covaxin-boosted sera was comparable to what has been observed in mRNA vaccine-boosted sera against the Omicron variant," Reuters quoted Bharat Biotech as saying in a statement. Citing the …

Maximising the boost: The Hindu Editorial on mixing COVID-19 vaccines
2 years, 11 months ago

Maximising the boost: The Hindu Editorial on mixing COVID-19 vaccines

The Hindu  

Heralding a new frontier in India’s vaccination programme, the apex drug regulator has approved two more vaccines under emergency use authorisation, and an antiviral drug. Despite three vaccines being available, India has overwhelmingly been reliant on Covishield and that is a matter of concern as a new chapter in the vaccination programme unfolds. The new directives say that “precaution doses”, …

In Boost to India's Covid Fight, 2 Vaccines, Covovax & Corbevax, and 1 Anti-Viral Pill Cleared in a Single Day
2 years, 11 months ago

In Boost to India's Covid Fight, 2 Vaccines, Covovax & Corbevax, and 1 Anti-Viral Pill Cleared in a Single Day

News 18  

Expanding India’s vaccine basket, the Central Drug Authority has approved the Serum Institute of India’s COVID-19 vaccine Covovax, Biological E’s jab Corbevax and anti-Covid pill Molnupiravir for restricted use in emergency situation. It also had recommended granting restricted emergency use approval to the drug Molnupiravir for treatment of adult patients with COVID-19 and who have high risk of progression of …

2 more Covid vaccines Covovax and Corbevax, and anti-viral drug Molnupiravir cleared for use in India
2 years, 11 months ago

2 more Covid vaccines Covovax and Corbevax, and anti-viral drug Molnupiravir cleared for use in India

India TV News  

Covovax, Corbevax vaccine latest news: The Government has approved two more Covid vaccines and an anti-viral drug for use in India. Health Minister Dr. Mansukh Mandaviya said that the Central Drugs Standard Control Organisation under the Ministry of Health and Family Welfare has given emergency use authorization approval to COVID-19 vaccines Covovax and Corbevax and Anti-viral drug Molnupiravir. "CORBEVAX vaccine …

Coxavin gets DCGI nod for use among 12-18 age group
2 years, 11 months ago

Coxavin gets DCGI nod for use among 12-18 age group

Hindustan Times  

New Delhi The Drugs Controller General of India on Saturday approved Covaxin for use in children between the ages of 12 and 18, a significant step towards opening vaccinations to the age group that has so far remained ineligible in India’s immunisation programme against Covid-19. The approval from DCGI came nearly 10 weeks after the subject expert committee of the …

'Slavish Mentality': CJI Says Covaxin Found Effective, But Many Complained Because Jab 'Made In India'
3 years ago

'Slavish Mentality': CJI Says Covaxin Found Effective, But Many Complained Because Jab 'Made In India'

News 18  

Chief Justice of India N V Ramana on Thursday presented the Dr Ramineni Foundation’s awards to vaccine maker Bharat Biotech’s Managing Director Krishna Ella and several others for their meritorious services. Speaking at the awards function late Thursday night, CJI Ramana said there is a tendency among Telugu speaking people to underestimate fellow Telugus in spite of one’s great achievements. …

Coronavirus Updates: Maha Sees 854 New Covid-19 Cases, 11 Deaths; Omicron Tally Rises to 48
3 years ago

Coronavirus Updates: Maha Sees 854 New Covid-19 Cases, 11 Deaths; Omicron Tally Rises to 48

News 18  

As the World Health Organization grants an emergency approval to Serum Institute of India’s Covovax, a top Indian government scientist has recommended that it be used as a booster shot to counter the threat posed by the emerging omicron variant of coronavirus, India Today reported. French Prime Minister Jean Castex says the Omicron variant will be the dominant strain of …

Vaccine Hesitancy Greatest Threat in Overcoming Covid: Adar Poonawalla
3 years, 1 month ago

Vaccine Hesitancy Greatest Threat in Overcoming Covid: Adar Poonawalla

News 18  

Serum Institute of India CEO Adar Poonawalla on Wednesday termed vaccine hesitancy as the greatest threat in overcoming the COVID-19 pandemic while urging all adults to get vaccinated at the earliest. He said that 200 million doses of the COVID-19 vaccine were lying with the states and people should get themselves vaccinated as soon as possible. Vaccine hesitancy is now …

100-crore Milestone Achieved Through Made-in-India Covid Vaccines: Dr VK Paul
3 years, 2 months ago

100-crore Milestone Achieved Through Made-in-India Covid Vaccines: Dr VK Paul

News 18  

As the total Covid-19 vaccine doses administered in India crossed the 100-crore milestone, Covid taskforce chief Dr VK Paul said on Thursday this was a remarkable feat and had been achieved through the vaccines manufactured in India. FOLLOW | Coronavirus LIVE Updates: India Scripts History, Tweets PM Modi on 100 Crore Vaccine Feat, Expresses Gratitude to Doctors, Nurses “Today, India …

Health Minister Discussed Emergency Use of India’s Covaxin with WHO
3 years, 2 months ago

Health Minister Discussed Emergency Use of India’s Covaxin with WHO

The Quint  

"We are aware that many people are waiting for WHO's recommendation for Covaxin to be included in the #COVID19 Emergency Use Listing, but we cannot cut corners - before recommending a product for emergency use, we must evaluate it thoroughly to make sure it is safe and effective," the global health organisation had said in a tweet. Our goal is …

WHO 'Deeply Concerned' Over Covid Vaccines Approved for Emergency Use Not Being Recognised in All Countries: Official
3 years, 2 months ago

WHO 'Deeply Concerned' Over Covid Vaccines Approved for Emergency Use Not Being Recognised in All Countries: Official

News 18  

The World Health Organisation is deeply concerned that COVID-19 vaccines that have proven to be effective and have been approved by the global health body for emergency use are not being recognised in all countries, an official said on Thursday. Addressing a press briefing, Dr Bruce Aylward, Senior Advisor to WHO Director General Dr Tedros Adhanom Ghebreyesus, said the organisation …

WHO 'deeply concerned' over Covid vaccines approved for emergency use not being recognised in all countries
3 years, 2 months ago

WHO 'deeply concerned' over Covid vaccines approved for emergency use not being recognised in all countries

India TV News  

The World Health Organisation is “deeply concerned” that COVID-19 vaccines that have proven to be effective and have been approved by the global health body for emergency use are not being recognized in all countries, an official said on Thursday. Addressing a press briefing, Dr. Bruce Aylward, Senior Advisor to WHO Director-General Dr. Tedros Adhanom Ghebreyesus, said the organization again …

India Has Done Better Than Any Country Across World in Vaccination: Bharat Biotech CMD
3 years, 4 months ago

India Has Done Better Than Any Country Across World in Vaccination: Bharat Biotech CMD

News 18  

India has done better than any country in the world as regards to affordability and the reach to the people of COVID-19 vaccines, Bharat Biotech Chairman and Managing Director Krishna Ella said on Sunday. About the contribution and efforts of Bharat Biotech in regards to vaccination efforts, Ella said that apart from Covaxin, the company has also developed a intranasal …

Covaxin production to get boost as govt approves manufacturing facility in Gujarat's Ankleshwar
3 years, 4 months ago

Covaxin production to get boost as govt approves manufacturing facility in Gujarat's Ankleshwar

India TV News  

Union Health Minister Mansukh Mandaviya on Tuesday informed that the government has approved a vaccine manufacturing facility for the production of Bharat Biotech's Covaxin in Gujarat's Ankleshwar. From January 16 to August 5, 44.42 crore doses of Covishield were supplied by Serum Institute of India and 6.82 crore doses of Covaxin by Bharat Biotech for the National COVID-19 Vaccination Programme. …

Bharat Biotech's Covaxin shows 77.8% efficacy in Phase 3 trial
3 years, 5 months ago

Bharat Biotech's Covaxin shows 77.8% efficacy in Phase 3 trial

India Today  

Bharat Biotech concluded the final analysis of its Covid-19 vaccine Covaxin and announced the safety and efficacy analysis data from Phase 3 clinical trials on Saturday. The indigenously developed vaccine demonstrated 93.4 per cent efficacy against severe symptomatic Covid-19 and 63.6 per cent efficacy against SARS-CoV-2 B.1.617.2, known as the Delta variant. Covaxin demonstrated 63.6 per cent efficacy against the …

Covaxin effectively neutralises both Alpha, Delta variants of Covid-19: US' top health institute
3 years, 5 months ago

Covaxin effectively neutralises both Alpha, Delta variants of Covid-19: US' top health institute

India TV News  

India's Covaxin, developed by Bharat Biotech in collaboration with the Indian Council of Medical Research, effectively neutralises both Alpha and Delta variants of coronavirus, the US' National Institute of Health has said. The NIH said results of two studies of blood serum from people who had received Covaxin suggest that the vaccine generates antibodies that effectively neutralise the B.1.1.7 and …

Pfizer's Covid-19 Vaccine to Get Nod in India Soon, CEO Says Deal 'In Final Stage'
3 years, 6 months ago

Pfizer's Covid-19 Vaccine to Get Nod in India Soon, CEO Says Deal 'In Final Stage'

News 18  

Pfizer CEO Albert Bourla on Tuesday said his US-based company is in the final stages of getting approval for its Covid-19 vaccine from the Indian government, adding that when approved, the pharma giant will supply one billion doses to India within this year. We have pledged to provide one billion doses of Covid-19 vaccine this year to nations under the …

The Science Behind Covid-19 Vaccines Approved by India - News18
3 years, 6 months ago

The Science Behind Covid-19 Vaccines Approved by India - News18

News 18  

Indian drugmaker Zydus Cadila said on Thursday it has applied to the country’s drug regulator for emergency use approval of its Covid-19 vaccine, which showed a 66.6% efficacy against positive cases in an interim analysis. The development comes a day after Cipla on Tuesday received the approval from the Drugs Controller General of India to import Moderna’s coronavirus vaccine for …

India may firm up plans to export Bharat Biotech’s Covaxin
3 years, 7 months ago

India may firm up plans to export Bharat Biotech’s Covaxin

Hindustan Times  

New Delhi: India has received enquiries from other countries for the export of the indigenous Covid 19 vaccine Covaxin jointly developed by Bharat Biotech and the Indian Council of Medical Research, according to government officials aware of the development. In February Bharat Biotech announced that it has signed a pact with Ocugen Inc, allowing the US-based biopharmaceutical firm to co-develop, …

COVID-19 vaccine: Covaxin effective against Indian, UK COVID-19 strains, says Bharat Biotech
3 years, 7 months ago

COVID-19 vaccine: Covaxin effective against Indian, UK COVID-19 strains, says Bharat Biotech

Firstpost  

The study was conducted in collaboration with the National Institute of Virology and Indian Council of Medical Research, Bharat Biotech said Bharat Biotech on Sunday said its COVID-19 vaccine ‘‘Covaxin’’ has been found to be effective against coronavirus strains found in India and the UK. Citing a study published in peer-reviewed medical journal Clinical Infectious Diseases, the Hyderabad-based vaccine major …

Covaxin Effective Against New Coronavirus Strains, Says Bharat Biotech
3 years, 7 months ago

Covaxin Effective Against New Coronavirus Strains, Says Bharat Biotech

News 18  

Bharat Biotech on Sunday said its COVID-19 vaccine 'Covaxin' has been found to be effective against coronavirus strains found in India and the UK. Citing a study published in peer-reviewed medical journal Clinical Infectious Diseases, the Hyderabad-based vaccine major noted that vaccination with Covaxin produced neutralising titres against all key emerging variants tested, including B.1.617 and B.1.1.7, first identified in …

COVAXIN effective against coronavirus strains found in India, UK
3 years, 7 months ago

COVAXIN effective against coronavirus strains found in India, UK

India TV News  

Vaccination with Bharat Biotech's COVID-19 vaccine - COVAXIN, has produced neutralising titres against all key emerging variants tested, including the B.1.617 and B.1.1.7, first identified in India and the United Kingdom, the vaccine manufacturer informed on Sunday. As per an infographic, a modest reduction in neutralisation by a factor of 1.95 was observed against the B.1.617 variant compared to the …

COVAXIN effective against coronavirus strains found in India, UK
3 years, 7 months ago

COVAXIN effective against coronavirus strains found in India, UK

Deccan Chronicle  

New Delhi: Vaccination with Bharat Biotech's COVID-19 vaccine - COVAXIN, has produced neutralising titres against all key emerging variants tested, including the B.1.617 and B.1.1.7, first identified in India and the United Kingdom, the vaccine manufacturer informed on Sunday. As per an infographic, a modest reduction in neutralisation by a factor of 1.95 was observed against the B.1.617 variant compared …

India's second coronavirus wave causing global 'crisis' as COVID-19 vaccine supplies disrupted
3 years, 7 months ago

India's second coronavirus wave causing global 'crisis' as COVID-19 vaccine supplies disrupted

ABC  

The global vaccine supply chain, already under extreme pressure, has been thrown into disarray by the COVID-19 crisis devastating India. Key points: So far, India has been unable to supply 80 million of the doses it had agreed to give COVAX COVAX is a collaboration of organisations that was set up to share vaccines fairly around the world India falling …

Covid vaccines: India is one of the world’s top 10 buyers but it still has nowhere near enough
3 years, 7 months ago

Covid vaccines: India is one of the world’s top 10 buyers but it still has nowhere near enough

CNN  

CNN — India has the world’s biggest vaccine producing capacity but is suffering a devastating second wave of coronavirus infections – just as supplies of Covid-19 vaccines for its huge population are running low. The government has purchased at least 205.5 million doses of Covid-19 vaccines, according to data from the Duke Global Health Innovation Center, placing India in the …

Bharat Biotech's Covaxin shows 78 per cent efficacy in phase-3 interim analysis
3 years, 8 months ago

Bharat Biotech's Covaxin shows 78 per cent efficacy in phase-3 interim analysis

India Today  

Bharat Biotech's vaccine Covaxin has shown the efficacy of 78 per cent against mild, moderate and severe cases of Covid-19, as per Phase III interim analysis results, the vaccine maker said on Wednesday. It further noted that the second interim data of the Phase III study also showed that chances of hospitalisation due to the infectious disease were reduced by …

Serum Institute's 2nd COVID-19 vaccine likely to be launched in September
3 years, 8 months ago

Serum Institute's 2nd COVID-19 vaccine likely to be launched in September

India TV News  

Serum Institute of India, the world's biggest Covid-19 vaccine maker, is hopeful of launching its second vaccine for coronavirus — Covovax — by September this year, CEO Adar Poonawalla announced on Saturday. "Covovax trials finally begin in India; the vaccine is made through a partnership with Novavax and Serum Institute of India," said Adar Poonawalla. the CEO of world's biggest …

Ocugen seeks to sell 100 million doses of 'Made in India' Covaxin in US
3 years, 9 months ago

Ocugen seeks to sell 100 million doses of 'Made in India' Covaxin in US

India Today  

Ocugen Inc seeks to sell 100 million doses of India’s state-backed Covid-19 vaccine Covaxin in the United States this year, the US firm’s chief executive Shankar Musunuri told Reuters on Monday. Musunuri said Ocugen aimed to launch the two-dose vaccine in the United States in the second quarter of 2021, initially with imported shots before beginning production there. Musunuri said …

Pakistan to get 45 million ’Made In India’ vaccine under GAVI alliance: Report
3 years, 9 months ago

Pakistan to get 45 million ’Made In India’ vaccine under GAVI alliance: Report

Live Mint  

Pakistan will be getting 45 million doses of Oxford-AstraZeneca's coronavirus vaccine, being manufactured in India, under the Global Alliance for Vaccines and Immunisation, for inoculating 45 million people. As per officials, Pakistan would receive the first batch of AstraZeneca's Covid-19 vaccine made by the Serum Institute of India by mid-March and the rest of it is expected to arrive by …

Coronavirus | India to get 97 million vaccine doses from COVAX
3 years, 10 months ago

Coronavirus | India to get 97 million vaccine doses from COVAX

The Hindu  

India is likely to get nearly 97 million doses of the AstraZeneca vaccine, nearly half of it by March end, under an agreement with the international COVAX facility. The latter has an agreement with Covax — a joint undertaking of the Coalition for Epidemic Preparedness Innovations, Global Alliance for Vaccines and the WHO to ensure that at least 20% of …

Watch | Inside the world's biggest vaccine production hub
3 years, 10 months ago

Watch | Inside the world's biggest vaccine production hub

The Hindu  

Serum Institute of India is the world's largest vaccine manufacturer by number of doses produced. It is estimated that about 65% of the children in the world receive at least one vaccine manufactured by the Serum Institute. The Central government placed a purchase order with the Serum Institute of India for 11 million doses of Oxford COVID-19 vaccine, Covishield, at …

Another Vaccine in India? Poonawalla Says Covovax Shown ‘Excellent Results’, Hopes to Launch it by June
3 years, 10 months ago

Another Vaccine in India? Poonawalla Says Covovax Shown ‘Excellent Results’, Hopes to Launch it by June

News 18  

A day after Serum Institute of India sought the Drugs Controller General of India’s approval to conduct a small domestic trial of the Novavax coronavirus vaccine, its Chief Executive Officer Adar Poonawalla on Saturday the company is hopeful of launching the vaccine by June this year. Poonawalla said that SII’s partnership with Novavax, a vaccine undergoing trials for effectiveness against …

Covaxin jab effective against UK variant of coronavirus, claims study
3 years, 10 months ago

Covaxin jab effective against UK variant of coronavirus, claims study

Firstpost  

Hyderabad: Covaxin, developed by Bharat Biotech, has the ability to neutralise the UK variant of the coronavirus, according to a preprint review by bioRxiv, a free online archive and distribution service for unpublished preprints in the life sciences. Bharat Biotech performed the plaque reduction neutralisation test using sera collected from the 26 recipients of Covaxin and tested them against the …

India has plenty of coronavirus vaccines but few takers
3 years, 10 months ago

India has plenty of coronavirus vaccines but few takers

Live Mint  

Most of the world is struggling to secure enough vaccines to inoculate their populations. India launched one of the world’s largest coronavirus vaccination drives on Saturday, setting in motion a complex deployment plan aimed at stemming the wide spread of infections across a nation of more than 1.3 billion people. India’s domestic vaccine program administers one of two shots: the …

The Hindu Explains | How effective are the two COVID-19 vaccines rolled out in India, and are there concerns about safety?
3 years, 11 months ago

The Hindu Explains | How effective are the two COVID-19 vaccines rolled out in India, and are there concerns about safety?

The Hindu  

The story so far: Two COVID-19 vaccines, Covaxin and Covishield, after being granted emergency use authorisation, were rolled out on January 16 across India to inoculate 3 crore healthcare and frontline workers in the first phase of the vaccination drive. While Covaxin is produced under a collaboration between Bharat Biotech and the Indian Council of Medical Research, Covishield has been …

Discover Related